Transfection of p27kip1 threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells

Oncology

Volumn 63, Issue 4, 2002, Pages 398-404

  Kudo, Yasusei ^a   Kitajima, Shojiro ^a   Sato, Sunao ^a   Ogawa, Ikuko ^a   Miyauchi, Mutsumi ^a   Takata, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cell cycle; Degradation; Oral squamous cell carcinoma; P27Kip1; Proteasome; Transfection

Indexed keywords

ALANINE; ECDYSONE; MUTANT PROTEIN; PONASTERONE A; PROTEIN P27; PROTEIN SUBUNIT; THREONINE; UBIQUITIN;

ARTICLE; CANCER CELL; CELL COUNT; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; WILD TYPE;

ALANINE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRY; GENE THERAPY; HUMANS; MOUTH NEOPLASMS; MUTATION; THREONINE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036969476     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066222     Document Type: Article

References (28)

1. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
2. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
3. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
4. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
5. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:682-685.
6. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M: Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999;13:1181-1189.
7. Kip1. EMBO J 1997;16:5334-5344.
8. Kip1 protein: Prognostic implications in primary breast cancer. Nat Med 1997;2:227-230.
9. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-3385.
10. Kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997;94:6380-6385.
11. Loda M, Cukor B, Tam SW, Lavin P, Fiorenti-no M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;2:231-234.
12. Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat Med 1997;2:222-225.
13. Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 1997;88:625-629.
14. Kip1 is an indicator of malignant behavior of oral squamous cell carcinomas. Cancer 1998;83:2447-2455.
15. Kip1. J Clin Invest 1996;97:1983-1988.
16. Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 1997;14:2283-2289.
17. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P: Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997;57:5441-5445.
18. Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 1997;15:2991-2997.
19. Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res 1998;58:3448-3454.
20. KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene 1999;18:1663-1676.
21. Kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell lines. Int J Cancer 2000;88:377-383.
22. Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res 2000;6:916-923.
23. Muller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Ansorge W, Huttner W, Eilers M: Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 1997;15:2561-2576.
24. Kip1. Genes Dev 1997;11:1464-1478.
25. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193-199.
26. Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999;1:207-214.
27. Skp2 complex through phosphorylated Thr187 in p27. Curr Biol 1999;9:661-664.
28. Kudo Y, Kitajima S, Ogawa I, Sato S, Miyauchi M, Takata T: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001;61;7044-7047.